D J Fryauff

Summary

Affiliation: Naval Medical Center
Country: USA

Publications

  1. ncbi Changes in the total leukocyte and platelet counts in Papuan and non Papuan adults from northeast Papua infected with acute Plasmodium vivax or uncomplicated Plasmodium falciparum malaria
    Walter R J Taylor
    The US Navy Medical Research Unit no 2, Jakarta, Indonesia
    Malar J 7:259. 2008
  2. ncbi The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia
    D J Fryauff
    Malaria Program, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910 7500, USA
    Ann Trop Med Parasitol 96:447-62. 2002
  3. ncbi Performance of the OptiMAL assay for detection and identification of malaria infections in asymptomatic residents of Irian Jaya, Indonesia
    D J Fryauff
    United States Naval Medical Research Unit Number Two, Jakarta, Indonesia
    Am J Trop Med Hyg 63:139-45. 2000
  4. ncbi Lymphocyte proliferative response and subset profiles during extended periods of chloroquine or primaquine prophylaxis
    D J Fryauff
    U S Naval Medical Research Unit No 2, Jakarta, Irian Jaya, Indonesia
    Antimicrob Agents Chemother 40:2737-42. 1996
  5. ncbi Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis
    D J Fryauff
    US Naval Medical Research Unit No 2, Jakarta, Indonesia
    J Infect Dis 177:1762-5. 1998
  6. ncbi Onset of clinical immunity to Plasmodium falciparum among Javanese migrants to Indonesian Papua
    J K Baird
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:557-64. 2003
  7. ncbi The T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia
    J D Maguire
    United States Naval Medical Research Unit No 2, U S Embassy Jakarta, Unit 8132, NAMRU TWO, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 95:559-72. 2001
  8. ncbi Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia
    W R Taylor
    U S Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Clin Infect Dis 28:74-81. 1999
  9. ncbi Cyclospora cayetanensis among expatriate and indigenous populations of West Java, Indonesia
    D J Fryauff
    U S Naval Medical Research Unit No 2, Jakarta, Indonesia
    Emerg Infect Dis 5:585-8. 1999
  10. ncbi Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua
    M J Barcus
    United States Naval Medical Research Unit No.2, American Embassy Jakarta, FPO AP 96520-8132, USA
    Ann Trop Med Parasitol 97:565-74. 2003

Collaborators

  • J K Baird
  • S L Hoffman
  • A L Richards
  • J D Maguire
  • C Ohrt
  • T R Jones
  • M J Bangs
  • T E Wellems
  • D A Fidock
  • H Basri
  • M J Barcus
  • Walter R J Taylor
  • T L Richie
  • H Marwoto
  • I R F Elyazar
  • T Nomura
  • S Owusu-Agyei
  • H S Nagesha
  • W R Taylor
  • Emiliana Tjitra
  • Hasan Basri
  • Hendra Widjaja
  • Thomas L Richie
  • Samuel Baso
  • Taufik Taufik
  • H A Hanafi
  • I Wiady
  • E Ayomi
  • G J Casey
  • J C Wootton
  • J C Reeder
  • X Su
  • K A Koram
  • G C Utz
  • T F McCutchan
  • A F Cowman
  • J M Carlton
  • A I Susanti
  • F N Binka
  • D Rathore
  • F K Nkrumah
  • H A del Portillo
  • W E Collins
  • H Widjaja
  • E Tjitra
  • D Braitman
  • D Tang
  • H Picarima
  • A Ganjar
  • J Berman
  • G S Murphy
  • G M Beavers
  • G E Tetreault
  • B M El Sawaf

Detail Information

Publications16

  1. ncbi Changes in the total leukocyte and platelet counts in Papuan and non Papuan adults from northeast Papua infected with acute Plasmodium vivax or uncomplicated Plasmodium falciparum malaria
    Walter R J Taylor
    The US Navy Medical Research Unit no 2, Jakarta, Indonesia
    Malar J 7:259. 2008
    ..There are limited data on the evolution of the leukocyte and platelet counts in malaria patients...
  2. ncbi The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia
    D J Fryauff
    Malaria Program, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910 7500, USA
    Ann Trop Med Parasitol 96:447-62. 2002
    ..sundaicus...
  3. ncbi Performance of the OptiMAL assay for detection and identification of malaria infections in asymptomatic residents of Irian Jaya, Indonesia
    D J Fryauff
    United States Naval Medical Research Unit Number Two, Jakarta, Indonesia
    Am J Trop Med Hyg 63:139-45. 2000
    ..The OptiMAL assay is not approved for diagnostic use but is commercially available for research purposes only...
  4. ncbi Lymphocyte proliferative response and subset profiles during extended periods of chloroquine or primaquine prophylaxis
    D J Fryauff
    U S Naval Medical Research Unit No 2, Jakarta, Irian Jaya, Indonesia
    Antimicrob Agents Chemother 40:2737-42. 1996
    ..The results provide quantitative support for the safety of daily primaquine prophylaxis...
  5. ncbi Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis
    D J Fryauff
    US Naval Medical Research Unit No 2, Jakarta, Indonesia
    J Infect Dis 177:1762-5. 1998
    ..Anti-tetanus GMTs in placebo and chloroquine groups declined over 14 months to levels comparable to those of unvaccinated controls, but levels in the primaquine group remained significantly higher than in controls...
  6. ncbi Onset of clinical immunity to Plasmodium falciparum among Javanese migrants to Indonesian Papua
    J K Baird
    United States Naval Medical Research Unit No 2, American Embassy Jakarta, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 97:557-64. 2003
    ..6; CI=1.7-530; P=0.005), indicating the development of clinical immunity. A similar but less marked pattern appeared among the children investigated (OR=6.5; CI=0.8-285; P=0.06)...
  7. ncbi The T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia
    J D Maguire
    United States Naval Medical Research Unit No 2, U S Embassy Jakarta, Unit 8132, NAMRU TWO, FPO AP 96520 8132, USA
    Ann Trop Med Parasitol 95:559-72. 2001
    ..Validation requires exploration of the phenotype classifications based on the results of in-vivo tests, using genetic analyses that distinguish re-infection from recrudescence and detect microscopically subpatent parasitaemias...
  8. ncbi Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia
    W R Taylor
    U S Naval Medical Research Unit Number 2, Jakarta, Indonesia
    Clin Infect Dis 28:74-81. 1999
    ..Corresponding figures for doxycycline were 96.3% (95% CI, 85.4-99.6) and 98% (95% CI, 88.0-99.9), respectively. Daily azithromycin offered excellent protection against P. vivax malaria but modest protection against P. falciparum malaria...
  9. ncbi Cyclospora cayetanensis among expatriate and indigenous populations of West Java, Indonesia
    D J Fryauff
    U S Naval Medical Research Unit No 2, Jakarta, Indonesia
    Emerg Infect Dis 5:585-8. 1999
    ..We found that C. cayetanensis was the main protozoal cause of gastrointestinal illness and diarrhea in adult foreign residents during the wet season. The parasite rarely caused illness in the indigenous population or in children...
  10. ncbi Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua
    M J Barcus
    United States Naval Medical Research Unit No.2, American Embassy Jakarta, FPO AP 96520-8132, USA
    Ann Trop Med Parasitol 97:565-74. 2003
    ..falciparum and P. vivax...
  11. ncbi Malaria in a cohort of Javanese migrants to Indonesian Papua
    H Basri
    United States Naval Medical Research Unit No.2, American Embassy Jakarta, FPO AP 96520-8132, USA
    Ann Trop Med Parasitol 97:543-56. 2003
    ..Only one of the nine subjects who developed severe malaria (requiring intravenous quinine therapy) was a child, giving an odds ratio for a case of severe malaria being in an adult of 6.1 (P=0.08)...
  12. ncbi Comparative performance of the ParaSight F test for detection of Plasmodium falciparum in malaria-immune and nonimmune populations in Irian Jaya, Indonesia
    D J Fryauff
    U S Naval Research Unit No 2, APO AP 96520 8132, USA
    Bull World Health Organ 75:547-52. 1997
    ..vivax. The results suggest that comparison based on microscopy underestimated the performance of the ParaSight F test and that malaria immune status, irrespective of P. falciparum density, may influence the test's sensitivity...
  13. ncbi Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana
    S Owusu-Agyei
    Navrongo Health Research Center, Ghana
    Am J Trop Med Hyg 65:197-203. 2001
    ....
  14. ncbi Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia
    H S Nagesha
    Eijkman Institute for Molecular Biology, Jl Diponegoro 69, Jakarta 10430, Indonesia
    Trans R Soc Trop Med Hyg 95:43-9. 2001
    ..These results suggest that mutations in both dhfr and dhps genes are a good predictor of potential Fansidar treatment failure...
  15. ncbi Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria
    T Nomura
    Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 0425, USA
    J Infect Dis 183:1653-61. 2001
    ..vivax gene. This is evidence that the molecular events underlying P. vivax CQR differ from those in P. falciparum...
  16. ncbi Susceptibility to Leishmania major of different populations of Phlebotomus papatasi (Diptera: Psychodidae) from endemic and non-endemic regions of Egypt
    H A Hanafi
    U S Naval Medical Research Unit No 3, Cairo, Egypt
    Ann Trop Med Parasitol 92:57-64. 1998
    ..These observations provide the final piece of evidence that P. papatasi is a vector of L. major in Egypt...